Clinical Trials in Solna, Stockholm County
19 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 2Phase 3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart FailureLeft Ventricular Systolic Dysfunction
Merck Sharp & Dohme LLC342 enrolled105 locationsNCT05714085
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled268 locationsNCT06012240
Recruiting
Phase 3
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie698 enrolled316 locationsNCT04928846
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Solid TumorsHGGCancer Harboring BRAF Alterations+1 more
Fore Biotherapeutics254 enrolled67 locationsNCT05503797
Recruiting
Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
AbbVie1,280 enrolled279 locationsNCT06468228
Recruiting
Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
Ulcerative Colitis
AbbVie530 enrolled270 locationsNCT06880744
Recruiting
EFESO: Study on Juvenile Onset Eosinophilic Fasciitis
Eosinophilic Fasciitis
Meyer Children's Hospital IRCCS20 enrolled15 locationsNCT07348263
Recruiting
Phase 3
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Hidradenitis Suppurativa
AbbVie1,328 enrolled285 locationsNCT05889182
Recruiting
Phase 1Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
AbbVie130 enrolled32 locationsNCT06953960
Recruiting
Feeding Difficulties and Quality of Life in Children With Tracheal Cannula
Quality of Life (QOL)Swallowing DifficultiesTracheostomy+3 more
Karolinska Institutet80 enrolled2 locationsNCT06893458
Recruiting
Phase 3
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
Hyperthyroidism
Jan Calissendorff182 enrolled1 locationNCT04856488
Recruiting
Phase 2
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
TRIOCOL - The Study of Continued Advanced Medical Therapy or Colectomy in Patients With Ulcerative Colitis
Ulcerative Colitis (UC)
Region Stockholm500 enrolled1 locationNCT07347834
Recruiting
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
Hemophilia
Karolinska Institutet20 enrolled1 locationNCT02453542
Recruiting
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
Parkinson's Disease
AbbVie2,000 enrolled4 locationsNCT06937034
Recruiting
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes
Breast CancerBreast Neoplasms
Theodoros Foukakis100 enrolled1 locationNCT06052345
Recruiting
Phase 2
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Radiotherapy Side EffectCognitive ImpairmentBrain Tumor+4 more
Region Stockholm84 enrolled2 locationsNCT06051240
Recruiting
Not Applicable
Probiotic Supplementation in Extremely Preterm Infants in Scandinavia
Necrotizing EnterocolitisDeathSepsis Newborn+2 more
Region Stockholm1,600 enrolled1 locationNCT05604846